yttrium radioisotopes has been researched along with Anemia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Izumitani, S; Matsuo, H; Saeki, Y; Sakurashita, H; Taogoshi, T; Yoshikawa, H | 1 |
Fabregas, JC; Goodman, D; Hoffman, JE; Hosein, PJ; Koru-Sengul, T; Lossos, IS; Miao, F; Rosenblatt, JD; Serafini, AN; Stefanovic, A | 1 |
Dietlein, M; Engert, A; Eschner, W; Fischer, T; Pinkert, J; Schicha, H; Schnell, R; Schomäcker, K; Zimmermanns, B | 1 |
Adams, GP; Axworthy, D; Breitz, H; Bryan, K; Colcher, D; Fisher, DR; Gaffigan, S; Gentner, L; Goris, ML; Horak, ID; Knox, SJ; Tempero, M; Weiden, PL; Weiner, LM | 1 |
2 trial(s) available for yttrium radioisotopes and Anemia
Article | Year |
---|---|
Phase II study of (90)Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antibodies, Monoclonal; Fatigue; Female; Fever; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Radioimmunotherapy; Remission Induction; Thrombocytopenia; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.
Topics: Adult; Aged; Anemia; Antibodies, Monoclonal; Biotin; Colonic Neoplasms; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Radioimmunotherapy; Radiopharmaceuticals; Thrombocytopenia; Yttrium Radioisotopes | 2000 |
2 other study(ies) available for yttrium radioisotopes and Anemia
Article | Year |
---|---|
Safety of
Topics: Aged; Aged, 80 and over; Anemia; Antibodies, Monoclonal; Asian People; Female; Humans; Japan; Leukopenia; Lymphoma; Male; Middle Aged; Neutropenia; Radiopharmaceuticals; Retrospective Studies; Safety; Thrombocytopenia; Treatment Outcome; Yttrium Radioisotopes | 2019 |
[Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan. Clinical considerations, radiopharmacy, radiation protection, perspectives].
Topics: Anemia; Antibodies, Monoclonal; Chromatography, High Pressure Liquid; Humans; Lymphoma; Neutropenia; Quality Control; Radiation Protection; Radioimmunotherapy; Radionuclide Imaging; Thrombocytopenia; Yttrium Radioisotopes | 2005 |